Mazindol
Top View
- A Practical Guide to the Therapy of Narcolepsy and Hypersomnia Syndromes
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Rana Dadashova
- Use of Isoindoles for the Treatment of Neurobehavioral Disorders
- Adverse Events Reported with the Use of Mazindol in Adult Obese
- Current and Future Nonstimulants in the Treatment of Pediatric ADHD: Monoamine Reuptake Inhibitors, Receptor Modulators, And
- Differential Visualization of Dopamine and Norepinephrine Uptake Sites in Rat Brain Using [3H]Mazindol Autoradiography’
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Pathophysiological and Pharmacologic Aspects of the Sleep Disorder Narcolepsy
- Mazindol to Cardiac Norepinephrine Transporters: Kinetic and Equilibrium Studies
- Structure-Function Analysis of the Dopamine Transporter in the Presence of Synthetic Cathinones and Amphetamines Shari Melissa Radford
- (12) United States Patent (10) Patent No.: US 9,517,254 B2 Sitchon Et Al
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- The Actions of Dopamine and Psychostimulants Mark S
- (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
- Drugs and Human Performance Fact Sheets Technical Report Documentation Page 1
- SUMMARY of PRODUCT CHARACTERISTICS Pane (123I) Diagnosis
- Β2-Adrenoceptor Agonists in the Regulation of Mitochondrial